Interestingly, FOXF1 intensity in vWF-positive EC was decreased in PAH patients with or without a BMPR2 mutation (Fig. 6b), as were the mRNA levels of FOXF1 and ATM in PAH PAEC (Supplementary Fig. 6e). This evidence concerns the gene FOXF1 and pulmonary arterial hypertension.